Anti-CYP1A2, clone 499CT13.2.2

Anti-CYP1A2, clone 499CT13.2.2
Artikelnummer Größe Datenblatt Manual SDB Lieferzeit Menge Preis
NSJ-F53655-0.1ML 100 µl - -

3 - 10 Werktage*

702,00 €
 
In ascites with 0.09% sodium azide. This gene encodes a member of the cytochrome P450 superfamily... mehr
Produktinformationen "Anti-CYP1A2, clone 499CT13.2.2"
In ascites with 0.09% sodium azide. This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. The protein encoded by this gene localizes to the endoplasmic reticulum and its expression is induced by some polycyclic aromatic hydrocarbons (PAHs), some of which are found in cigarette smoke. The enzyme's endogenous substrate is unknown, however, it is able to metabolize some PAHs to carcinogenic intermediates. Other xenobiotic substrates for this enzyme include caffeine, aflatoxin B1, and acetaminophen. The transcript from this gene contains four Alu sequences flanked by direct repeats in the 3' untranslated region. Protein function: A cytochrome P450 monooxygenase involved in the metabolism of various endogenous substrates, including fatty acids, steroid hormones and vitamins (PubMed:9435160, PubMed:10681376, PubMed:11555828, PubMed:12865317, PubMed:19965576). Mechanistically, uses molecular oxygen inserting one oxygen atom into a substrate, and reducing the second into a water molecule, with two electrons provided by NADPH via cytochrome P450 reductase (NADPH--hemoprotein reductase) (PubMed:9435160, PubMed:10681376, PubMed:11555828, PubMed:12865317, PubMed:19965576). Catalyzes the hydroxylation of carbon-hydrogen bonds (PubMed:11555828, PubMed:12865317). Exhibits high catalytic activity for the formation of hydroxyestrogens from estrone (E1) and 17beta- estradiol (E2), namely 2-hydroxy E1 and E2 (PubMed:11555828, PubMed:12865317). Metabolizes cholesterol toward 25-hydroxycholesterol, a physiological regulator of cellular cholesterol homeostasis (PubMed:21576599). May act as a major enzyme for all-trans retinoic acid biosynthesis in the liver. Catalyzes two successive oxidative transformation of all-trans retinol to all-trans retinal and then to the active form all-trans retinoic acid (PubMed:10681376). Primarily catalyzes stereoselective epoxidation of the last double bond of polyunsaturated fatty acids (PUFA), displaying a strong preference for the (R,S) stereoisomer (PubMed:19965576). Catalyzes bisallylic hydroxylation and omega-1 hydroxylation of PUFA (PubMed:9435160). May also participate in eicosanoids metabolism by converting hydroperoxide species into oxo metabolites (lipoxygenase-like reaction, NADPH- independent) (PubMed:21068195). Plays a role in the oxidative metabolism of xenobiotics. Catalyzes the N-hydroxylation of heterocyclic amines and the O-deethylation of phenacetin (PubMed:14725854). Metabolizes caffeine via N3-demethylation (Probable). [The UniProt Consortium]
Schlagworte: Anti-CYPIA2, Anti-Cytochrome P450 4, Anti-Cytochrome P450-P3, Anti-Cytochrome P(3)450, Anti-Cytochrome P450 1A2, Anti-Cholesterol 25-hydroxylase, Anti-Hydroperoxy icosatetraenoate dehydratase, CYP1A2 Antibody
Hersteller: NSJ Bioreagents
Hersteller-Nr: F53655

Eigenschaften

Anwendung: WB, ELISA
Antikörper-Typ: Monoclonal
Klon: 499CT13.2.2
Konjugat: No
Wirt: Mouse
Spezies-Reaktivität: human
Immunogen: Portion of amino acids 255-282 from the human protein
Format: Purified

Handhabung & Sicherheit

Lagerung: -20°C
Versand: -20°C (International: -20°C)
Achtung
Nur für Forschungszwecke und Laboruntersuchungen: Nicht für die Anwendung im oder am Menschen!
Hier kriegen Sie ein Zertifikat
oder , um Analysenzertifikate anzufordern.
Bewertungen lesen, schreiben und diskutieren... mehr
Kundenbewertungen für "Anti-CYP1A2, clone 499CT13.2.2"
Bewertung schreiben
oder , um eine Produktbewertung abzugeben.
Zuletzt angesehen